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Glutaminyl-tRNA synthetase is thought to be absent
from organelles. Instead, Gln-tRNA is formed via the
transamidation pathway, the other route to this essen-
tial compound in protein biosynthesis. However, it was
previously shown that glutaminyl-tRNA synthetase ac-
tivity is present in Leishmania mitochondria. This work
identifies genes encoding glutaminyl- and glutamyl-
tRNA synthetase in the closely related organism Trypa-
nosoma brucei. Down-regulation of their respective
gene products by RNA interference showed that (i) they
are essential for the growth of insect stage T. brucei and
(ii) they are responsible for essentially all of the glutami-
nyl- and glutamyl-tRNA synthetase activity detected in
both the cytosol and the mitochondria. In vitro amino-
acylation experiments with the recombinant T. brucei
enzymes and total tRNA confirmed the identity of the
two aminoacyl-tRNA synthetases. Interestingly, T. bru-
cei uses the same eukaryotic-type glutaminyl-tRNA syn-
thetase to form mitochondrial and cytosolic Gln-tRNA.
The formation of Glu-tRNA in mitochondria and the cy-
toplasm is catalyzed by a single eukaryotic-type dis-
criminating glutamyl-tRNA synthetase. T. brucei, simi-
lar to Leishmania, imports all of its mitochondrial
tRNAs from the cytosol. The use of these two eukaryotic-
type enzymes in mitochondria may therefore reflect an
adaptation to the situation in which the cytosol and
mitochondria use the same set of tRNAs.
For protein synthesis, most organisms require 20 function-
ally different aminoacyl-tRNA synthetases, one for each amino
acid. These enzymes attach the cognate amino acid to the
corresponding tRNA species, e.g. glutaminyl-tRNA synthetase
(GlnRS)1 acylates tRNAGln with glutamine. However, in many
organisms, the formation of Gln-tRNA does not proceed
by direct aminoacylation. Rather, Gln-tRNA is synthesized
in a tRNA-dependent amidation of glutamate mischarged to
tRNAGln. Genomic and biochemical analyses indicate that the
pathways of Gln-tRNA formation evolved as distinct systems in
the three kingdoms (1). The eukaryotic cytoplasm uses GlnRS
exclusively, whereas bacteria and archaea utilize the transami-
dation pathway. Because of the bacterial origin of organelles,
the transamidation pathway is expected to be present in chlo-
roplasts and mitochondria. Biochemical data have shown that
most organelles lack GlnRS activity and instead use the indi-
rect transamidation pathway to Gln-tRNA formation (2).
Whereas in many eukaryotes all of the tRNAs necessary for
organellar translation are encoded on the mitochondrial ge-
nome, there are a large variety of organisms in which a vari-
able number of apparently essential mitochondrial tRNA genes
are missing. It has been shown that the lack of these genes is
generally compensated by import of the corresponding cytosolic
tRNAs (3). In all of the cases known, imported tRNAs originate
from nuclear genes encoding eukaryotic-type tRNAs also uti-
lized in cytosolic translation. An extreme situation is found in
the trypanosomatids such as Trypanosoma brucei and Leish-
mania, which have lost the entire set of mitochondrial tRNA
genes. These organisms must import all of the tRNAs neces-
sary for organellar protein synthesis. As a result, the bacterial-
type translation system of the mitochondria is forced to func-
tion with imported eukaryotic-type tRNAs only (4).
Surprisingly, it was shown that a mitochondrial GlnRS activity
exists in Leishmania (5). To investigate this finding at the
genome level, we decided to characterize Gln-tRNA and Glu-
tRNA formation in T. brucei in which RNA interference meth-
odology (6) and biochemical analysis could be used.
EXPERIMENTAL PROCEDURES
Cells—Procyclic T. brucei, stock 427, was grown at 27 °C in semi-
defined medium-79 medium supplemented with 5% fetal calf serum.
Cells were harvested at 3.5–4.5  107 cells/ml. Procyclic T. brucei,
strain 29–13, on which the RNAi knock-down cell lines are based was
grown in semi-defined medium-79 supplemented with 15% fetal calf
serum, 50 g/ml hygromycin, and 15 g/ml G418 (7). Cultures were
harvested at a density of 0.5–2  107 cells/ml.
Identifying T. brucei GlnRS and GluRS—The T. brucei databases
(tigrblast.tigr.org/er-blast/index.cgi?projecttba1 and www.sanger.
ac.uk/Projects/T_brucei/) were analyzed with the BLAST software using
default parameter settings to search for putative trypanosomal GlnRS
and GluRS genes using the corresponding cytosolic yeast enzymes
(www.yeastgenome.org/; GluRS, ORF YGL245W; GlnRS, ORF
YOR168W) as query sequences. Two ORFs showing 41 and 47% identity
to the yeast GlnRS and GluRS, respectively, were found. As expected for
eukaryotic-type GlnRS and GluRS, the trypanosomal proteins share a
high degree of sequence similarity (54%). Besides the eukaryotic-type
GlnRS and GluRS, no other ORFs showing any significant similarity to
either eukaryotic or bacterial-type GlnRS or GluRS or to any putative
Glu-tRNAGln amidotransferase were found in the T. brucei genome.
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RNA Interference—The RNAi constructs for the GlnRS and GluRS
knock-down experiments are based on the previously described (7) stem
loop construct carrying convenient cloning sites and a spacer corre-
sponding to 690 nucleotides of the trypanosomal spliced leader se-
quence. Fragments corresponding to the 5 part of the coding region of
the GlnRS ORF (28G16.175/region 33 to 619) or the GluRS ORF
(43.m00224/region 4 to 476) were PCR-amplified and inserted into
the corresponding sites of the modified stem loop vector. The resulting
plasmids carrying one gene fragment each were then used to insert the
same gene fragments in the opposite direction. The resulting RNAi
plasmids were linearized with NotI and transfected into the procyclic
T. brucei strain 29-13, which expresses T7 RNA polymerase and the
tetracycline repressor (7, 8). Selection with phleomycine, cloning, and
induction with tetracycline were done as described previously (9).
In Vitro Aminoacylation Using Cytosolic and Mitochondrial Extracts
of T. brucei—RNA-free cytosolic fractions were prepared as follows.
Washed T. brucei cells were hypotonically lysed at 1.2  109 cells/ml in
1 mM Tris-HCl, 1 mM EDTA, pH 8 by four passages through a 25-gauge
syringe needle. A quarter volume of 5 acylation buffer (250 mM Tris-
HCl, pH 7.5, 125 mM KCl, 40 mM MgCl2, 5 mM dithiothreitol) and NaCl
(final concentration 150 mM) was added. The extract was centrifuged for
25 min at 150,000  g at 4 °C, and the supernatant was applied to
DEAE-Sepharose equilibrated with 1 acylation buffer. The flow-
through fractions corresponding to RNA-free cytosol were frozen in
liquid N2 and stored at 70 °C until further use in the charging assays.
Mitochondrial fractions were prepared as follows: mitoplasts of T. bru-
cei were hypotonically purified as described previously (10), resus-
pended in 50-l aliquots at a concentration of 40 mg/ml in 20 mM
Tris-HCl, pH 8, 250 mM sucrose, and 2 mM EDTA, and frozen in liquid
N2. The purity of the mitoplast fraction was tested by immunoblots
using antibodies against the mitochondrial heat shock protein 60 and
the cytosolic protein pyruvate kinase as described previously (5). For
charging assays, the mitoplasts were thawed and centrifuged for 5 min
at 8,000  g at 4 °C. The pellet was resuspended in 1 acylation buffer
containing 1% CHAPS and spun for 5 min at 16,000  g at 4 °C. The
resulting supernatant fraction (5–20 l) was used for the charging
assays. No attempt was made to remove endogenous mitochondrial
tRNAs, because very little charging was observed in the absence of
added tRNAs. Aminoacylation was preformed as described previously
(5) using the indicated amounts of protein fractions and 4 g of
isolated total trypanosomal tRNA each.
Cloning of the T. brucei GlnRS and GluRS Genes and Expression of
the Gene Product—Oligonucleotides were synthesized, and DNAs were
sequenced by the Keck Foundation Biotechnology Resource Laboratory
at Yale University. The gene sequences of the T. brucei GlnRS
(28G16.175) and GluRS (43.m00224) were found at the T. brucei
GeneDB (www.genedb.org/genedb/tryp/index.jsp). The genes were
cloned by PCR from T. brucei genomic DNA using the Expand High
Fidelity PCR system (Roche Applied Science). The cloning and subse-
quent expression of the full-length T. brucei GlnRS ORF yielded an
insoluble protein; therefore, the predicted mitochondrial targeting se-
quence was removed (1 to 129 in 28G16.175). An N-terminal His6
tag was introduced into the truncated T. brucei GlnRS by PCR, and
cloning into a pET15b expression vector (Novagen, Madison, WI) was
achieved by adding a 5-NcoI and 3-NdeI restriction sites. Oligonucleo-
tide primers introduced a 5-NdeI site and a 3-XhoI site into the
full-length T. brucei GluRS ORF. A C-terminal His6 tag was added by
cloning the gene into the pET20b vector (Novagen, Madison, WI). All of
the proteins were expressed in the Escherichia coli BL21-CodonPlus
(DE3)-RIL strain (Stratagene, La Jolla, CA), which also expresses mi-
nor E. coli tRNA genes from a chloramphenicol-resistant vector. Cul-
tures of E. coli transformed with either the T. brucei GlnRS or GluRS
expression vectors were grown at 37 °C in LB medium (5 g of yeast
extract, 10 g of tryptone, and 10 g of NaCl, pH 7.0) with 0.1 mg/ml
ampicillin and 0.034 mg/ml chloramphenicol. At a cell density of A600 
0.8, the temperature was reduced to 30 °C, ampicillin was refreshed to
0.1 mg/ml, and recombinant protein expression was induced with 1 mM
isopropyl-1-thio--D-galactopyranoside. Upon induction, the LB me-
dium was brought to 1% ethanol to reduce the formation of inclusion
bodies. Growth was continued for 4 h post-induction, and cells were
harvested by centrifugation.
Enzyme Purification—The His6-tagged proteins were purified over a
nickel-nitrilotriacetic acid column as described previously (11). GlnRS
was further purified using an A¨KTA-fast protein liquid chromatogra-
phy system (Amersham Biosciences) by ion-exchange chromatography
on Mono S HR 5/5 (Amersham Biosciences). The pure GlnRS fraction
was dialyzed into 50 mM Tris-HCl, pH 7.5, 25% glycerol, 5 mM 2-mer-
captoethanol (2-ME), 0.05 mM phenylmethylsulfonyl fluoride, and 0.05
mM benzamidine-HCl, and stored at 80 °C. The GluRS was further
purified on a 5-ml HiTrap heparin HP column (Amersham Biosciences)
followed by gel filtration on Superdex 200 HR 10/30 (Amersham Bio-
sciences) and then prepared for storage as described above. The enzyme
fractions appeared to be 95% pure as judged by Coomassie Blue-
stained SDS-polyacrylamide gel electrophoresis (data not shown). Pro-
tein concentrations were determined by the Quantigold (Diversified
Biotech, Boston, MA) colloidal gold protein assay (12).
Preparation of T. brucei tRNA—Total T. brucei RNA (3.95 mg) was
dissolved in 1 ml of 0.1 M MOPS, pH 7.0, 1 mM EDTA, and 10 mM 2-ME
and loaded onto a Qiagen-tip 100 column (Qiagen Inc., Valencia, CA)
pre-equilibrated with 20 ml of 50 mM MOPS, pH 7.0, 15% isopropyl
alcohol, 1% Triton-X, and 5 mM 2-ME. After washing the column with
20 column volumes of 50 mM MOPS, pH 7.0, 0.2 M NaCl, and 5 mM
2-ME, the tRNA was eluted with 2 column volumes of 50 mM MOPS, pH
7.0, 0.75 M NaCl, 15% ethanol, and 5 mM 2-ME. Further deacylation of
tRNA and collection of tRNA was performed as described previously
(13). This preparation yielded 223 g of unfractionated tRNA, which
represented 6% of the total T. brucei RNA used as starting material.
Purity of the tRNA was 95% as determined by denaturing 12% poly-
acrylamide, 8 M urea gel electrophoresis.
Aminoacylation Assays—[14C]Gln (50 Ci/ml, 242 mCi/mmol) and
[14C]Glu (50 Ci/ml, 254 mCi/mmol) were from Amersham Biosciences.
Assays were performed essentially as described previously (14). Ami-
noacylation reactions were performed at 37 °C in 100 mM HEPES-Na,
pH 7.2, 60 mM KCl, 30 mM MgCl2, 10 mM ATP, 10 mM dithiothreitol, 10
M total T. brucei tRNA, and 50 M [14C]Gln or [14C]Glu using 100 nM
GlnRS or GluRS. The control reactions lacked tRNA or contained 60 M
of commercially available E. coli total tRNA (Roche Applied Science).
Sample workup and scintillation counting were carried out as before
(14). The identity of the amino acids attached to tRNAs was confirmed
by thin layer chromatography (data not shown) (1).
RESULTS
Analysis of the available T. brucei genome (www.genedb.org)
by BLAST searches revealed the lack of the genes encoding the
key enzyme of the transamidation pathway, Glu-tRNAGln
amidotransferase, whereas single genes encoding eukaryotic-
type GlnRS as well as a GluRS were detected. MITOPROT
analysis predicted the presence of an N-terminal mitochondrial
import signal for the T. brucei GlnRS and GluRS (probabilities
are 0.96 [GlnRS] and 0.92 [GluRS]). This is not the case for
other orthologous eukaryotic synthetases. Additional charac-
teristics of the T. brucei GlnRS and GluRS are discussed below.
Taken together, the genome search predicted that direct acy-
lation should generate Gln-tRNA and that single GlnRS and
GluRS enzymes should catalyze the formation of their cognate
aminoacyl-tRNAs in the cytoplasm and in the mitochondria of
T. brucei.
To test these predictions, we wanted to know whether the
GlnRS and GluRS homologues are essential for the survival of
T. brucei and where in the cell the gene products are localized.
Furthermore, it was important to confirm the predicted bio-
chemical activities of the two proteins and to investigate
whether they are responsible for all of the Gln-tRNA and Glu-
tRNA formation in both intracellular compartments or whether
independent redundant pathways may exist.
To answer the questions outlined above, we made use of
RNAi. This is the process in which the presence of a double-
stranded RNA in a cell causes specific degradation of the cor-
responding mRNA. RNAi was shown to be a powerful method
for the inhibition of gene expression in T. brucei (6–8, 15). It is
optimally suited for RNAi analysis because as a unicellular
eukaryote T. brucei is not prone to the recently recognized
problems of RNAi analysis in mammalian cells, which are
caused by the activation of interferon-mediated processes (16,
17). Therefore, unlike in mammalian cells, long double-
stranded RNAs can be used to induce RNAi. We therefore
established two transgenic T. brucei cell lines allowing tetra-
cycline-inducible expression of double-stranded RNA corre-
Mitochondrial Gln-tRNA Formation in T. brucei1162
sponding to the 5 regions of the putative GlnRS and GluRS
genes, respectively.
RNAi-induced Ablation of T. brucei GlnRS—The ablation of
the GlnRS homologue in T. brucei results in a growth arrest
90 h after the addition of tetracycline (Fig. 1A). Therefore, as
would be expected for a translation factor, the GlnRS homo-
logue is essential for the survival of insect stage T. brucei. To
measure the biochemical phenotype of the RNAi cell line, we
isolated an RNA-free cytosolic fraction from untreated cells and
from cells grown in the presence of tetracycline for 90 h. The
cytosolic fractions were then tested for the presence of GlnRS
and GluRS activities by in vitro aminoacylation assays using
labeled glutamine or glutamate and tRNAs isolated from total
cells as substrates (5). The results showed that the cytosolic
fractions from both uninduced and induced cells in which the
GlnRS was targeted still exhibit GluRS activity (Fig. 1B, left
panel), although a slight reduction to 70% is observed in
induced cells. The GlnRS activity in induced cells, however,
drops to 15–30% of the one measured in the uninduced cytosol
(Fig. 1B, right panel). Thus, these results show that the puta-
tive GlnRS gene encodes the trypanosomal enzyme responsible
for most if not all of the cytosolic Gln-tRNA formation.
How can the slight decline in GluRS activity in a cell line
expected to be specifically down-regulated for the GlnRS activ-
ity be explained? We think that this might be due to the fact
that although down-regulation of the GlnRS activity is the
primary phenotype of the cell line, the resulting arrest of pro-
tein synthesis will nonspecifically affect many other physiolog-
ical processes. This explanation is supported by the fact that
concomitant with the drop of GluRS activity a reduction of
methionyl-tRNA synthetase activity to 80% of the one found in
uninduced cells was observed (data not shown). The low level of
GlnRS activity that persists in the induced RNAi cell lines is
not unexpected, because RNAi is known to greatly reduce the
targeted mRNAs but generally does not eliminate them com-
pletely. The extent of the down-regulation depends on many
factors and appears to be gene-specific (15). Trypanosomal
GlnRS is predicted to contain an N-terminal mitochondrial
targeting signal, which raises the question whether it also
functions in mitochondria. To investigate this possibility, we
isolated mitochondria from uninduced and induced (90 h) cells.
The mitochondrial preparations were then used for in vitro
charging assays. The results (Fig. 1C) are essentially identical
to the ones obtained with the cytosol and demonstrate that in
T. brucei the same gene encodes both cytosolic and mitochon-
drial GlnRS. Furthermore, because essentially all of the GlnRS
activity was abolished in mitochondria of induced cells, these
results also show that direct acylation by GlnRS is the major
and probably the only pathway for the formation of mitochon-
drial glutaminyl-tRNA.
RNAi-induced Ablation of T. brucei GluRS—The results for
the RNAi cell line ablated for the trypanosomal GluRS homo-
logue are summarized in Fig. 2. The growth curve (Fig. 2A)
shows that GluRS is an essential protein whose depletion re-
sults in a growth arrest reminiscent of the one seen in the
GlnRS RNAi cell line. The same is true for the biochemical
phenotype (Fig. 2, B and C). As expected, the GluRS activity is
down-regulated while the GlnRS activity remains unaffected.
These data show that a eukaryotic-type GluRS encoded by a
single nuclear gene is responsible for all of the cytosolic and
mitochondrial GluRS activity that was detected in T. brucei.
A comparison of the two knock-down cell lines shows that the
specific activities for the two aminoacyl-tRNA synthetases,
measured in either the cytosolic or the mitochondrial fractions,
is similar in both cell lines. Furthermore, it was observed that
depletion of GluRS occurs faster and that RNAi inhibition
appears to be more efficient than the one observed for GlnRS.
Recombinant T. brucei GlnRS and GluRS Have the Predicted
in Vitro Activities—To confirm the identities of the T. brucei
GlnRS and GluRS, recombinant proteins were overexpressed
in E. coli and purified to 95% homogeneity (data not shown).
Total T. brucei tRNA was aminoacylated in vitro with T. brucei
GlnRS and GluRS. These enzymes clearly charged their respec-
tive cognate amino acids onto total T. brucei tRNA (Fig. 3).
Each enzyme reached an aminoacylation plateau of 2.5%.
FIG. 1. Characterization of growth and GlnRS/GluRS activi-
ties in RNAi cell lines down-regulated for GlnRS. A, growth
curves of the GlnRS RNAi cell line uninduced (grown without tetracy-
cline, TET) and induced for the expression of double-stranded RNA
(grown in the presence of tetracycline, TET). B, in vitro aminoacyla-
tion reactions using the indicated amounts of RNA-free cytosolic frac-
tions (CYT) from uninduced (TET) and induced (TET) cells as a
source of enzyme and total tRNA of T. brucei and [14C]Gln (right panel)
or [14C]Glu (left panel) as substrates. The background corresponding to
the aminoacylation activity measured in the absence of added tRNAs
(approximately 5% of the total activity) was determined for each reac-
tion and subtracted. C, same as B but detergent extracts of mitochon-
drial fractions (MIT) prepared from uninduced and induced cells were
used as a source of enzyme.
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This charging level is consistent with the amount of tRNAGln
and tRNAGlu present in total tRNA of T. brucei and of other
organisms (11, 18, 19). The fact that both synthetases charged
unfractionated tRNA to a similar level may be a reflection of
the discrimination properties of trypanosomal GluRS. Non-
discriminating GluRSs, which attach glutamate to tRNAGln in
addition to tRNAGlu, obviously attach approximately twice as
much glutamate to total tRNA (19). This property, which still
needs to be rigorously established for the T. brucei enzyme, is
essential for their role in the transamidation pathway of Gln-
tRNA formation (1, 20). Thus, the T. brucei GluRS is probably
a discriminating eukaryotic-type GluRS with 47% identity to
the discriminating GluRS from yeast cytoplasm. The eukary-
otic nature of the T. brucei GlnRS and GluRS enzymes is also
seen in their inability to utilize total E. coli tRNA as a sub-
strate (Fig. 3).
T. brucei GlnRS and GluRS Lack N-terminal Exten-
sions—As depicted schematically in Fig. 4, eukaryotic GlnRS
and GluRS generally have N-terminal extensions (from 123 to
264 amino acids) with regions of sequence conservation (21,
22). These extensions appear to be dispensable for aminoacy-
lation in yeast, but the human GlnRS requires the N-terminal
extension for catalytic activity (21, 23, 24). It has been sug-
gested that the N-terminal extensions are essential for protein-
protein interactions, which form the multi-aminoacyl-tRNA
synthetase complexes described in yeast and higher eukaryotes
(21, 23, 25). The need to form a multi-aminoacyl-tRNA synthe-
tase complex may also explain that the GluRS of higher eu-
karyotes is encoded by a large open reading frame consisting of
an in-frame fusion of GluRS and prolyl-tRNA synthetase (26).
Not much is known yet regarding the function of these higher
order aminoacyl-tRNA synthetase complexes, but in mice they
are essential (27). The surprising feature of T. brucei GlnRS
and GluRS is that they lack extensive N-terminal domains. In
addition, the T. brucei GluRS is a smaller protein, which lacks
the ProRS and linker domains found in higher eukaryotes (25).
Instead, T. brucei GlnRS and GluRS possess short (44 and 36
amino acids, respectively) N-terminal regions predicted to be
mitochondrial targeting sequences. Preliminary sequence data
(ORF LmjF15.1440) show that Leishmania major also encodes
a GlnRS with a similarly short N-terminal extension as does
the metazoan parasite Schistosoma mansoni (28). The lack of
the N-terminal domains suggests that the GlnRS and/or GluRS
in these organisms do not form a higher order complex.
DISCUSSION
Using a combination of RNAi-based in vivo studies and in
vitro aminoacylation assays with recombinant proteins, we
have shown that direct acylation by a eukaryotic-type GlnRS is
the route for mitochondrial Gln-tRNA formation in T. brucei. In
line with this result, we find that the mitochondrial GluRS is of
FIG. 2. Characterization of growth and GlnRS/GluRS activi-
ties in RNAi cell lines down-regulated for GluRS. A, growth
curves of the GluRS RNAi cell line uninduced (grown without tetracy-
cline, TET) and induced for the expression of double-stranded RNA
(grown in the presence of tetracycline, TET). B, in vitro aminoacyla-
tion reactions using the indicated amounts of RNA-free cytosolic frac-
tions (CYT) from uninduced (TET) and induced (TET) cells as a
source of enzyme and total tRNA of T. brucei and [14C]Gln (right panel)
or [14C]Glu (left panel) as substrates. The background corresponding to
the aminoacylation activity measured in the absence of added tRNAs
(approximately 5% of the total activity) was determined for each reac-
tion and subtracted. C, same as B but detergent extracts of mitochon-
drial fractions (MIT) prepared from uninduced and induced cells were
used as a source of enzyme.
FIG. 3. Recombinant T. brucei GlnRS and GluRS and their
respective aminoacylation activities. Aminoacyl-tRNA formation
([14C]Gln-tRNA and [14C]Glu-tRNA) is shown as the percent of total
tRNA from T. brucei or E. coli. The enzyme [14C]amino acid and tRNA
used are as follows: E, T. brucei GlnRS, Gln, T. brucei tRNA; ,
T. brucei GluRS, Glu, T. brucei tRNA; , T. brucei GlnRS, Gln, E. coli
tRNA; f, T. brucei GluRS, Glu, E. coli tRNA. The level of charging in
the absence of tRNA was the same as with E. coli tRNA (data not
shown).
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the discriminating eukaryotic type. This is expected since the
presence of a bacterial-type non-discriminating GluRS would
be harmful in the absence of the transamidation pathway.
Interestingly, in both cases, single nuclear genes for GlnRS and
GluRS encode both the cytoplasmic and the mitochondrial ac-
tivities. Dual targeting of proteins to the cytosol and mitochon-
dria is not unusual. It was also described for aminoacyl-tRNA
synthetases (29, 30). However, this is the first reported case
involving GlnRS and GluRS. Different mechanisms by which
proteins are simultaneously targeted to the cytosol and mito-
chondria have been described previously (31), but currently we
do not know which one is operating in T. brucei.
T. brucei lacks mitochondrial tRNA genes, and its mitochon-
drial tRNAs consist of an imported fraction of the cytosolic pool.
This leads to the paradoxical situation that mitochondrial
translation based on bacterial-type ribosomes must proceed
exclusively with imported eukaryotic-type tRNAs (32). The use
of eukaryotic-type GlnRS and GluRS to aminoacylate the eu-
karyotic-type tRNAGln and tRNAGlu may therefore represent
an adaptation to this situation. Besides T. brucei, there are two
other organisms in which mitochondrial GlnRS activity has
been detected. Leishmania tarentolae mitochondria also form
Gln-tRNA by direct acylation (5), and the mitochondrial trans-
lation depends exclusively on imported eukaryotic-type tRNAs.
However, there are some interesting differences between the
two species. T. brucei probably has a single tRNAUUG
Gln isoaccep-
tor, a fraction of which is imported into mitochondria (18). In
addition, as shown in this work, it has a single dually targeted
GlnRS. The situation is more complex in L. tarentolae where
two tRNAGln isoacceptors exist: (i) tRNAUUG
Gln , which is in part
imported into mitochondria, and (ii) tRNACUG
Gln , which appears
to be cytosol-specific (33). In line with this finding, it was
shown that L. tarentolae contains distinct cytosolic and mito-
chondrial GlnRS activities exhibiting distinct substrate speci-
ficities toward the two isoacceptors (5). However, the genes
encoding the GlnRS activities have not been identified, and the
lack of RNAi methodologies in Leishmania (34) has hampered
a more detailed investigation. Mitochondrial GlnRS activity
was also detected in Tetrahymena mitochondria (35). The Tet-
rahymena mitochondrial genome encodes only a subset of
tRNAs, and the mitochondrial tRNAGln species is imported
from the cytosol (36). The type of GlnRS(s) that exists in Leish-
mania and Tetrahymena mitochondria has not been deter-
mined; however, based on our results in T. brucei, they can be
expected to be of the eukaryotic type.
The observed correlation between the presence of mito-
chondrial GlnRS activity and the mitochondrial import of its
tRNAGln substrate suggests that mitochondrial GlnRS might
be limited to organisms that import eukaryotic-type tRNAGln
from the cytosol. Eukaryotes with mitochondria-encoded
tRNAGln may use the transamidation pathway or possess a
bacterial-type GlnRS. The bacterial ancestor of mitochondria
probably had a complete set of tRNA genes. A lack of mito-
chondrial tRNA genes and import of cytosolic tRNAs is there-
fore a derived trait (4). This finding suggests that the mito-
chondrial GlnRS activity was only acquired later in
evolution.
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